| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/10/2008 | EP1967206A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967205A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967204A1 Multiple vaccination including serogroup c meningococcus |
| 09/10/2008 | EP1967203A1 Polysaccharide vaccine for staphylococcal infections |
| 09/10/2008 | EP1966370A1 Method for treating disseminated cancer |
| 09/10/2008 | EP1966369A1 Improved method for expansion of tumour-reactive t-lymphocytes for immunotherapy of patients with cancer |
| 09/10/2008 | EP1966246A2 Methods and compositions for needleless delivery of antibodies |
| 09/10/2008 | EP1966245A1 Anti-cd19 antibodies with reduced immunogenicity |
| 09/10/2008 | EP1966244A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
| 09/10/2008 | EP1966243A1 Tgf-beta binding compositions |
| 09/10/2008 | EP1966242A1 Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
| 09/10/2008 | EP1966241A2 Anti-orthopoxvirus recombinant polyclonal antibody |
| 09/10/2008 | EP1965827A2 Treatment of conditions involving demyelination |
| 09/10/2008 | EP1965784A1 Combination comprising combretastatin and anticancer agents |
| 09/10/2008 | EP1651247B1 Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin |
| 09/10/2008 | EP1631312B1 Compositions and methods for the therapy of inflammatory bowel disease |
| 09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
| 09/10/2008 | EP1408996B1 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 09/10/2008 | EP1289570B1 Liposomal encapsulation of alpha-emitters and uses thereof |
| 09/10/2008 | EP1200124B1 Erythropoietin-immunoglobulin fusion proteins |
| 09/10/2008 | EP1159967B1 Tumor vaccines |
| 09/10/2008 | EP1141017B1 Characterization of the soc/crac calcium channel protein family |
| 09/10/2008 | EP1131356B1 Monoclonal anti alpha-D (ITGAD) antibody for use in the treatment of CNS injuries caused by trauma |
| 09/10/2008 | EP1060247B1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |
| 09/10/2008 | EP0983767B1 Preventives or remedies for the treatment of multiple sclerosis containing antagonist anti-IL-6-receptor antibodies |
| 09/10/2008 | EP0905140B1 Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use |
| 09/10/2008 | EP0873415B1 Fusion protein delivery system and uses thereof |
| 09/10/2008 | EP0771322B1 Abundant extracellular products and methods for their production and use |
| 09/10/2008 | CN101263159A Compositions and methods for the diagnosis and treatment of tumor |
| 09/10/2008 | CN101262885A Pharmaceutical compositions containing sc(Fv)2 |
| 09/10/2008 | CN101262884A Anti A beta antibody formulation |
| 09/10/2008 | CN101262883A Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| 09/10/2008 | CN101262882A Lawsonia vaccine and methods of use thereof |
| 09/10/2008 | CN101262881A Adjuvation through cross- beta structure |
| 09/10/2008 | CN101262774A Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 09/10/2008 | CN101260386A Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 09/10/2008 | CN101260156A Immunoglobulin single variant antigen binding domain and specific construct thereof |
| 09/10/2008 | CN101260154A Novel mhc II associated peptides |
| 09/10/2008 | CN101260152A Method for down-regulating Osteoprotegerin ligand activity |
| 09/10/2008 | CN101260149A Streptococcus antigens |
| 09/10/2008 | CN101260148A Hybrid and tandem expression of neisserial proteins |
| 09/10/2008 | CN101259275A Yolk antibody feed additive and injection for resisting sheep virosis and preparation thereof |
| 09/10/2008 | CN101259274A Yolk antibody feed additive and injection for resisting canine distemper and preparation thereof |
| 09/10/2008 | CN101259273A Yolk antibody feed additive and injection for resisting canine distemper and canine parvovirus disease and preparation thereof |
| 09/10/2008 | CN101259272A Yolk antibody feed additive and injection for resisting porcine reproductive and respiratory syndrome and preparation thereof |
| 09/10/2008 | CN101259271A Anti-diarrhea yolk antibody feed additive and injection for goat and preparation thereof |
| 09/10/2008 | CN101259270A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 09/10/2008 | CN101259269A Freeze-drying hepatitis A varicella attenuation combined vaccine and producing method thereof |
| 09/10/2008 | CN101259268A Rabies recombination vaccine with I type herpesvirus as carrier for animal and preparation |
| 09/10/2008 | CN101259267A Compound type dual duplex locating type intracellular vaccine |
| 09/10/2008 | CN101259266A Preadipocyte heterologous vaccine and preparation method and application thereof |
| 09/10/2008 | CN100417414C Methods for treating cancer using an immunotoxin |
| 09/10/2008 | CN100417413C Novel use of thymosin alpha protogene |
| 09/09/2008 | US7424529 System using host bus adapter connection tables and server tables to generate connection topology of servers and controllers |
| 09/09/2008 | US7423138 Antiproliferative agents; anticancer agents; urogenital systems; insertion into cells |
| 09/09/2008 | US7423137 Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses |
| 09/09/2008 | US7423127 For diagnosis and therapy |
| 09/09/2008 | US7423125 Antibodies to VEGF-C |
| 09/09/2008 | US7423118 IAPS associated cell cycle proteins, compositions and methods of use |
| 09/09/2008 | US7423023 Enhancement of immune response using targeting molecules |
| 09/09/2008 | US7423016 Genetic engineering; inducting immunology response |
| 09/09/2008 | US7423008 From mutated Streptomyces argillaceous; antitumor agents; hypercalcemia; hypercalcuria |
| 09/09/2008 | US7422886 Human Phosphoinositide I3 Kinase p110 Delta which interacts with p85, has a broad phosphinositide specificity and is sensitive to the same kinase inhibitors as PI3 Kinase p110A; selectively expressed in leucocytes; enhanced expression in most melanomas |
| 09/09/2008 | US7422869 Method for diagnosing infectious diseases |
| 09/09/2008 | US7422849 Hybridizing sample with a nucleic acid molecule to a transcript of gene wherein said transcript is RNA or cDNA; determining hybridization as a determination of expression of gene |
| 09/09/2008 | US7422848 Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/09/2008 | US7422755 Vaccine against Haemophilus influenzae type a, Haemophilus influenzae type b, Staphylococcus aureus, and Staphylococcus epidermidis; glycoconjugate of cell wall polysaccharide from Bacillus pumilus Sh 18 |
| 09/09/2008 | US7422754 Neisseria meningitidis (Nm) polynucleotides and polypeptides; diagnostic. prophylactic and therapeutic uses |
| 09/09/2008 | US7422753 treating obsessions and compulsions, in particular trichotillomania, by local administration of Clostridial toxin; low dose, intramuscular administration of botulinum toxin |
| 09/09/2008 | US7422752 Mutant forms of EtxB and CtxB and their use as carriers |
| 09/09/2008 | US7422751 Epstein-barr-virus-specific immunization |
| 09/09/2008 | US7422749 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 09/09/2008 | US7422748 Combining antigen or in vivo generator with a surfactant or with a mixture of surfactants having an overall HLB number of between 5 and 15 and comprising: ethoxylated derivatives of ester of fatty acids and ethoxylated derivatives of oils |
| 09/09/2008 | US7422747 Transgenic plant-based vaccines |
| 09/09/2008 | US7422746 Administering immunity linkers, wherein the linker molecules comprise first binding site and second binding site, wherein second binding site binds to the target and wherein the individual has a pre-existing immune response to first binding site |
| 09/09/2008 | US7422745 Methods of treating cancer with vαβ3-specific antibodies |
| 09/09/2008 | US7422744 Integrin mediated diseases like angiogenesis or restenosis; Vitaxin (a humanized monoclonal) antibody and a LM609 grafted antibody exhibiting selective binding affinity to alpha v beta 3 |
| 09/09/2008 | US7422743 Using DCRS5 (SEQ ID NOs: 1 or 2) or p19 (SEQ ID NOs: 5 or 6) cytokine receptors agonist or antagonist to treat rheumatoid arthritis, asthma, allergies, chronic obstructive pulmonary disorder, interstitial lung disorder, inflammatory bowel disorder, inflammatory skin disorder |
| 09/09/2008 | US7422742 Gene therapy using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders, administering antibody or antigen-binding fragment thereof that specifically binds IL-5 |
| 09/09/2008 | US7422741 VEGFR-3 fusion proteins |
| 09/09/2008 | US7422740 Capable of inhibiting the cell division cycle in a target cell; for therapy of proliferative cell disorders and intracellular pathogens |
| 09/09/2008 | US7422739 Anti-CD20 antibodies |
| 09/09/2008 | US7422738 Combined cancer treatment methods using antibodies to aminophospholipids |
| 09/09/2008 | CA2171369C The use of virulence factors of pathogens to improve liposomal delivery of antibiotics and/or vaccines |
| 09/09/2008 | CA2144855C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 09/09/2008 | CA2135833C Antigen carbohydrate compounds and their use in immunotherapy |
| 09/04/2008 | WO2008106657A2 Encapsulated amyloid-beta peptides |
| 09/04/2008 | WO2008106430A2 Heterologous expression of extremophile heat shock proteins and chaperones in microorganisms to increase tolerance to toxic compounds |
| 09/04/2008 | WO2008106393A2 Immunogenic compositions and methods for treating and preventing animal infections |
| 09/04/2008 | WO2008106131A2 Combination therapy for treatment of immune disorders |
| 09/04/2008 | WO2008106116A2 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases |
| 09/04/2008 | WO2008105978A1 Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization |
| 09/04/2008 | WO2008105959A2 Cerebrospinal fluid purification system |
| 09/04/2008 | WO2008105886A2 HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 09/04/2008 | WO2008105740A1 A new immunoglobulin against helicobacter pylori |
| 09/04/2008 | WO2008105560A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/04/2008 | WO2008105504A1 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same |
| 09/04/2008 | WO2008105174A1 Liposome for induction of cell-mediated immunity |
| 09/04/2008 | WO2008104385A1 Method for the treatment of amyloidoses |